Drugs & medicalClass II

BioFire Diagnostics, LLC recalls BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems

Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.

Read the official notice →
Date
2025-06-04
Country
United States
Brand
BioFire Diagnostics
Product
BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems
Classification
Class II
Units
International distribution in the country of Singapore.
Category
Drugs & medical
Source
FDA · Device

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More BioFire Diagnostics recalls

  1. 2026-05-13
  2. US
    Drugs & medicalClass II

    BioFire Diagnostics, LLC recalls Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485

    Respiratory/sore throat panel test may result in false negative results and control failures.

    FDA · DeviceBioFire Diagnostics, LLCUS Nationwide distribution in the states of MS, TX MN, VA.Official notice →
  3. US
    Drugs & medicalClass II

    BioFire Diagnostics, LLC recalls BioFire Joint Infection (JI) Panel REF: RFIT-ASY-0138, 30 test Kit.

    Contamination to in-vitro diagnostic test may result in false positives.

    FDA · DeviceBioFire Diagnostics, LLCWorldwide - US Nationwide distribution in the states of TX, NC, UT, MD and the…Official notice →
  4. 2025-12-03
  5. US
    Drugs & medicalClass II

    BioFire Diagnostics, LLC recalls BioFire Respiratory Panel 2.1, IVD, REF: 423742 (30 test kit)

    Due to unintended movement of pouch chemistry, nucleic acid test may result in elevated risk of false negative results and risk of control failures.

    FDA · DeviceBioFire Diagnostics, LLCUS:AZ, FL,GA,ID NC, NH, NJ, NY, OR, PA, SC OUS: NoneOfficial notice →
  6. 2025-04-16
  7. US
    Drugs & medicalClass II

    BioFire Diagnostics, LLC recalls FilmArra Pneumonia Panel plus (Pneumoplus), REF: RFIT-LBL-0374

    Increased risk of control failures and false negative test results with multiplexed nucleic acid test.

    FDA · DeviceBioFire Diagnostics, LLCOUS International Distribution to countries of: France, Italia, Spain,…Official notice →
  8. 2024-09-18
  9. US
    Drugs & medicalClass II

    BioFire Diagnostics, LLC recalls FILMARRAY 2.0 INSTRUMENT, REF: FLM2-ASY-0001, FLM2-ASY-0001-W

    Some automated in vitro diagnostic modules and instruments manufactured or serviced between May 2022 and May 2024 were calibrated with internal equipment that may lead modules and instruments to report higher melting…

    FDA · DeviceBioFire Diagnostics, LLCWorldwide - US Nationwide distribution including in the states of NC, TX, OH,…Official notice →
  10. 2024-08-28
  11. US
    Drugs & medicalClass II

    BioFire Diagnostics, LLC recalls BIOFIRE FILMARRAY Pneumonia Panel plus, REF: RFIT-ASY-0143

    Pneumonia panels have an increased risk of control failures due to an issue in the manufacturing process, which could lead to delayed results for the customer.

    FDA · DeviceBioFire Diagnostics, LLCWorldwide - US Nationwide distribution in the states of WV, IN, AL and the…Official notice →
All 21 BioFire Diagnostics recalls →

Other drugs & medical recalls in the United States

  1. 2025-06-11
  2. US
    Drugs & medicalClass II

    Torrent Pharma Inc. recalls Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA;…

    CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.

    FDA · DrugTorrent Pharma Inc.U.S. Nationwide.Official notice →
  3. US
  4. 2025-06-04
  5. US
    Drugs & medicalClass II

    Onkos Surgical, Inc. recalls a. Segmental Stem, Cemented, Straight, 100MM, 1 EACH; Model Numbers: CS-09100-03M, CS-10100-03M. b. Segmental Stem, Cemented, Straight,…

    Potential for breach of Tyvek seals.

    FDA · DeviceOnkos Surgical, Inc.Product was shipped from Onkos' distribution in Olive Branch, MS to consignees…Official notice →
  6. US
    Drugs & medicalClass II

    Ortho-Clinical Diagnostics, Inc. recalls VITROS Chemistry Products CRP Slides. One sales unit contains 5 cartridges, of 18 slides per cartridge, for a total of 90 slides.

    Product was incorrectly assigned GEN 88 instead of GEN 83 on product carton, foil wrapper, and cartridge (cart) label.

    FDA · DeviceOrtho-Clinical Diagnostics, Inc.Worldwide - US Nationwide distribution in the states of AR, AZ, CO, FL, GA,…Official notice →
  7. US
    Drugs & medicalClass II

    Cardinal Health 200, LLC recalls Catalog No. 8888160119; Umbilical Vessel Catheter Insertion Tray with 2.5 and 5 French UVCs

    Packaging defect may compromise sterility of the product. Use of a non-sterile product on the patient could lead to infection in neonates.

    FDA · DeviceCardinal Health 200, LLCWorldwide - US Nationwide distribution including in the states of AK, AL, AR,…Official notice →
  8. US
    Drugs & medicalClass II

    NxStage Medical Inc recalls NxStage PureFlow-B Solution. Catalog numbers: RFP-400, RFP-401, RFP-402, RFP-403, RFP-404, RFP-406, RFP-453, RFP-454, RFP-456.

    Potential for the perimeter seal on the small chamber of the two-chamber bag to fail causing the electrolyte fluid to splash into the face of the user when attempting to open the peel seam to mix the two chambers prior…

    FDA · DeviceNxStage Medical IncUS Nationwide distribution.Official notice →
See all drugs & medical recalls →